Clinical Trials Browser

Phase 1/2 × Unknown × samarium Sm-153 lexidronam × Clear all

NCT00121095 2007-12-21

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Phase 1/2 Unknown

Prostatic Neoplasms